[go: up one dir, main page]

MY196025A - Novel T Cell Receptors and Immune Therapy Using the Same - Google Patents

Novel T Cell Receptors and Immune Therapy Using the Same

Info

Publication number
MY196025A
MY196025A MYPI2019003103A MYPI2019003103A MY196025A MY 196025 A MY196025 A MY 196025A MY PI2019003103 A MYPI2019003103 A MY PI2019003103A MY PI2019003103 A MYPI2019003103 A MY PI2019003103A MY 196025 A MY196025 A MY 196025A
Authority
MY
Malaysia
Prior art keywords
taa
antigen recognizing
recognizing constructs
novel
tcr
Prior art date
Application number
MYPI2019003103A
Inventor
Dominik Maurer
Leonie Alten
Sebastian Bunk
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102016123859.7A external-priority patent/DE102016123859B3/en
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of MY196025A publication Critical patent/MY196025A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to antigen recognizing constructs against a tumor associated antigen (TAA) derived from the target protein DDB1 and CUL4 associated factor 4-like 2 (DCAF4L2). The invention in particular provides novel T cell receptor (TCR) based molecules which are selective and specific for the TAA of the invention. The TCR of the invention, and TAA binding fragments derived therefrom, are of use for the diagnosis, treatment and prevention of TAA expressing cancerous diseases. Further provided are nucleic acids encoding the antigen recognizing constructs of the invention, vectors comprising these nucleic acids, recombinant cells expressing the antigen recognizing constructs and pharmaceutical compositions comprising the compounds of the invention.
MYPI2019003103A 2016-12-08 2017-12-07 Novel T Cell Receptors and Immune Therapy Using the Same MY196025A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662431580P 2016-12-08 2016-12-08
DE102016123859.7A DE102016123859B3 (en) 2016-12-08 2016-12-08 New T cell receptors and their use in immunotherapy
PCT/EP2017/081893 WO2018104478A1 (en) 2016-12-08 2017-12-07 Novel t cell receptors and immune therapy using the same

Publications (1)

Publication Number Publication Date
MY196025A true MY196025A (en) 2023-03-07

Family

ID=67874111

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019003103A MY196025A (en) 2016-12-08 2017-12-07 Novel T Cell Receptors and Immune Therapy Using the Same

Country Status (6)

Country Link
CL (1) CL2019001537A1 (en)
CO (1) CO2019006926A2 (en)
IL (1) IL267131A (en)
MY (1) MY196025A (en)
NZ (1) NZ754366A (en)
PH (1) PH12019501263A1 (en)

Also Published As

Publication number Publication date
CO2019006926A2 (en) 2019-09-18
IL267131A (en) 2019-08-29
NZ754366A (en) 2022-02-25
PH12019501263A1 (en) 2020-01-20
CL2019001537A1 (en) 2019-10-11

Similar Documents

Publication Publication Date Title
PH12019501241A1 (en) Novel t cell receptors and immune therapy using the same
PH12020550600A1 (en) Novel engineered t cell receptors and immune therapy using the same
CA3045233A1 (en) Novel t cell receptors and immune therapy using the same
MX2023003463A (en) T cell receptors and immune therapy using the same against prame positive cancers.
WO2018172533A3 (en) T cell receptors and immune therapy using the same against prame positive cancers
PH12019500312A1 (en) T cell receptors and immune therapy using the same
PH12019502847A1 (en) Novel t cell receptors and immune therapy using the same
CR20190276A (en) NEW T-CELL RECEPTORS AND IMMUNE THERAPY THAT USES THEM
MX395287B (en) NEW T LYMPHOCYTE RECEPTORS AND IMMUNOTHERAPY BASED ON THEIR USE.
MX2020001996A (en) Anti-cd137 molecules and use thereof.
JOP20200313A1 (en) Dll3-cd3 bispecific antibodies
PH12019500122A1 (en) Bispecific antibody-like binding proteins specifically binding to cd3 and cd123
MX2019006045A (en) Psma targeting trispecific proteins and methods of use.
MX2018010824A (en) Inducible binding proteins and methods of use.
EA202191027A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TYPES OF TUMORS
PH12019500571A1 (en) Anti-pd-1 antibodies
EP4279086A3 (en) Compositions and methods for treating cancer with anti-cd19 immunotherapy
PH12019501263A1 (en) Novel t cell receptors and immune therapy using the same
MY195101A (en) Novel T Cell Receptors and Immune Therapy Using the Same
EA202090712A1 (en) NEW GENETIC ENGINEERED T-CELL RECEPTORS AND IMMUNE THERAPY WITH THEIR USE
EA201991139A1 (en) NEW T-CELL RECEPTORS AND IMMUNOTHERAPY WITH THEIR APPLICATION
EA201992002A1 (en) T-CELL RECEPTORS AND IMMUNE THERAPY OF PRAME-POSITIVE CANCER DISEASES WITH THEIR APPLICATION
AR110682A1 (en) T-CELL RECEIVERS AND IMMUNE THERAPY USING THEM
EA201990488A1 (en) NEW T-CELL RECEPTORS AND IMMUNOTHERAPY WITH THEIR APPLICATION